Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: k


Summaries of Product Characteristics 1 - 30 of 109
  1  2  3  4  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Kabiven infuusioneste, emulsio SPC 2023-05-11

PL

Resepti

Kabiven Perifer infuusioneste, emulsio SPC 2023-05-11

European Medicines Agency's website:
Kadcyla - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Kaftrio - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Kalcipos 500 mg tabletti, kalvopäällysteinen SPC 2022-01-13

PL

Resepti/itsehoito

Kalcipos-D 500 mg-10 mikrog purutabletti SPC 2022-06-13

PL

Resepti/itsehoito

Kalcipos-D 500 mg-10 mikrog tabletti, kalvopäällysteinen SPC 2022-01-19

PL

Resepti

Kalcipos-D forte 500 mg-20 mikrog purutabletti SPC 2022-05-31

PL

Resepti/itsehoito

Kalcipos-D forte 500 mg-20 mikrog tabletti, kalvopäällysteinen SPC 2022-05-17

PL

Itsehoito

Kalcipos-D mite 500 mg-5 mikrog tabletti, kalvopäällysteinen SPC 2022-01-19

PL

Resepti

Kalciumfolinat Stada 10 mg-ml injektioneste, liuos SPC 2020-03-31

PL

Itsehoito

Kaleorid 1 g depottabletit SPC 2024-04-21

PL

Itsehoito

Kaleorid 750 mg ja 1 g depottabletit SPC 2023-04-21

European Medicines Agency's website:
Kaletra - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Kalii chloridum-Natrii chloridum B. Braun 1,5+9mgml 3+9mgml inf SPC FI 2012-10-04 clean.doc

PL

Itsehoito

Kalisol 50 mg-ml oraaliliuos SPC 2022-05-19

PL

Itsehoito

Kaliumjodidi G-L Pharma 65 mg tabletti SPC 2024-01-10

PL

Itsehoito

Kaliumjodidi SERB 65 mg tabletti SPC 2023-07-06

PL

Resepti

Kaliumklorid Braun 150 mg/ml infuusiokonsentraatti SPC 2019-12-17

PL

Resepti/itsehoito

Kaliumklorid Orifarm 1 g depottabletti SPC 2021-02-23

PL

Itsehoito

Kaliumklorid Orifarm 750 mg depottabletti SPC 2023-12-21

PL

Itsehoito

Kaliumklorid Sandoz 1 g depottabletti SPC 2022-08-15

PL

Itsehoito

Kaliumklorid Sandoz 750 mg depottabletti SPC 2021-10-06

European Medicines Agency's website:
Kalydeco - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Kandrozid 4 mg, 8 mg, 16 mg, 32 mg tabletti SPC 2022-09-21

European Medicines Agency's website:
Kanjinti - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Kanuma - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Kapruvia - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Karvea - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Karvezide - EMA: EPAR PI
Finnish Swedish

  1  2  3  4  |  Next 30   >